National Medicare Prescription Drug Congress Features Nation's Leading Regulators and Experts in the New Legislation
  • The Leading Forum on the New Medicare Prescription Drug Coverage Legislation and Its Implications for Pharmaceutical Manufacturers, PBMs, Health Plans and Providers
  • February 25 - 27, 2004
  • Hyatt Regency on Capitol Hill, Washington, DC
Contact: Paul Tunnecliff
800-684-4549 phone

WASHINGTON DC USA -- HEALTHCARE UPDATE NEWS SERVICETM - NOVEMBER 24, 2003: In response to the passage of the watershed Medicare prescription drug legislation, the National Medicare Prescription Drug Congress has been scheduled on February 25 - 27, 2004 at the Hyatt Regency on Capitol Hill in Washington, DC.


Drew E. Altman, Ph.D.
President and Chief Executive Officer, Henry J. Kaiser Family Foundation and Former Commissioner of the Department of Human Services, New Jersey, Washington, DC

Richard J. Davidson (Invited)
President, American Hospital Association, Washington, DC

Robert S. Galvin, MD, MBA (Invited)
Director, Global Healthcare, General Electric Company, Founding Member, The Leap Frog Group and Vice Chair, Washington Business Group on Health, Fairfield, CN

John Iglehart
Founding Editor, Health Affairs, Washington, DC

Mark B. McClellan, MD, Ph.D.
Commissioner of Food and Drugs, Food and Drug Administration, Rockville, MD

Robert D. Reischauer, Ph.D. (Invited)
President, The Urban Institute and Former Director, Congressional Budget Office, Washington, DC

Leonard D. Schaeffer (Invited)
Chairman and Chief Executive Officer, Wellpoint Health Networks and Former Administrator, Healthcare Financing Administration, Thousand Oaks, CA

Thomas Scully
Administrator, Centers for Medicare and Medicaid Services, Department of Health and Human Services, Washington, DC

James Sheehan, Esq.
Chief of the Civil Division, Assistant U.S. Attorney, U.S. Attorney's Office for the Eastern District of Pennsylvania, Philadelphia, PA

Sidney Taurel (Invited)
President, Chairman and Chief Executive Officer, Eli Lilly and Chairman, Pharmaceutical Research & Manufacturers of America (PhRMA), Indianapolis, IN

Barrett Toan (Invited)
President and Chief Executive Officer, Express Scripts, Inc., Maryland Heights, MO


John Bentivoglio, Esq.
Partner, Arnold and Porter, Former Special Counsel for Healthcare Fraud and Chief Privacy Officer, United States Department of Justice, Washington, DC

Anthony L. Farino
Partner, PricewaterhouseCoopers, Chicago, IL

Jack Hartwig, Esq.
Leader, Health Care and Life Sciences Investigations Team, Deloitte & Touche and Former Deputy Inspector General for Investigations, Department of Health and Human Services, Philadelphia, PA

Brenton L. Saunders, JD, MBA
Senior Vice President, Global Compliance and Business Practices, Schering-Plough Corporation, Past President, Health Care Compliance Association, and Founder and Chair-elect, International Association of Privacy Officers, Kenilworth, NJ

Bert Spilker, PhD, MD, FCP, FFPM
President, Bert Spilker & Associates, Clinical Professor, Pharmacy Practice, University of Minnesota, and Former Senior Vice President of Scientific and Regulatory Affairs, PhRMA, Bethesda, MD

  • The Roles of CMS and FDA as Purchasers/Regulators
  • The Roles of Pharmaceutical Manufacturers and PBMs
  • The Roles of Health Plans and Providers
  • The Ramifications for Employer-Sponsored Retiree Drug Coverage
  • The Medicare Endorsed Prescription Drug Discount Card
  • The Drug Reimportation Debate
  • The Implications for Pharmaceutical Market Structure and Profitability
  • Health Affairs, the preeminent journal of the health policy sphere,
  • Harvard Health Policy Review, published by Exploring Policy in Health Care at Harvard University,


For sponsorship and exhibit information review the Promotional Opportunities pages on the Congress website: or contact: REGISTRATION INFORMATION:

For further registration info, call 800-684-4549, go to the Congress website at, email:, or write:
    Medicare Congress Office
    7790 Barberry Ave.
    Yucca Valley, CA USA 92284

For changes or additions, please email your request to:

For removal of your e-mail address, please click the link below for "SafeUnsubscribe" to automatically remove your address from the list.